期刊文献+

唑来膦酸注射液致流感样不良反应1例 被引量:7

One case of influenza-like adverse reaction induced by zoledronic acid injection
原文传递
导出
摘要 1例老年女性患者应用唑来膦酸注射液治疗骨质疏松症,出现了恶心、呕吐、心悸等流感样症状及白细胞的异常升高,未见其他感染,4 d后体温逐步恢复正常水平。 An old female patient experienced an abnormal increase in WBC and influenza-like symptoms,including nausea,vomiting and cardiopalmus,after administration of zoledronic acid injection for osteoporosis treatment.No infections were found,and the body temperature gradually recovered to normal level 4 days later.
作者 李铮
出处 《中国新药杂志》 CAS CSCD 北大核心 2011年第9期849-850,共2页 Chinese Journal of New Drugs
关键词 唑来膦酸注射液 流感样症状 不良反应 zoledronic acid injection influenza-like symptom adverse reactions
  • 相关文献

参考文献4

  • 1彭六保,崔巍.唑来膦酸的临床应用研究进展[J].中国新药与临床杂志,2007,26(3):237-240. 被引量:36
  • 2BONNEL RA, BUSSE GD. Zolendronic acid (marketed as reclast) : renal impairment and acute renal failure[ J]. Drug Safety Newsletter, 2009,2(2) : 26-27.
  • 3黄海英.双膦酸盐类药物的不良反应[J].中国药房,2002,13(1):41-42. 被引量:3
  • 4ROSEN ES, GORDEN D, KAMINSKI M, et al. Long-term efficacy and safely of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myelomaor breast carcinoma: a randomized, double-blind, multicenter, comparative trial[ J]. Cancer, 2003,98 ( 8 ) : 1735 - 1744.

二级参考文献29

  • 1张文武 主编.急诊内科学[M].北京:人民卫生出版社,2001.507-575.
  • 2CROUCHER P,JAGDEV S,COLEMAN R.The anti-tumor potential of zoledronic acid[J].Breast,2003,12 Suppl 2:30-36.
  • 3MUNDY GR,YONEDA T,HIRAGA T.Preclinical studies with zoledronic acid and other bisphosphonates:impact on the bone microenvironment[J].Semin oncol,2001,28(2 Suppl 6):35-44.
  • 4MAJOR PP,COLEMAN RE.Zoledronic acid in the treatment of hypercalcemia of malignancy:results of the international clinical development program[J].Semin oncol,2001,28 (2 Suppl 6):17-24.
  • 5MAJOR PP,LORTHOLARY A,HON J,et al.Zoledronic acid is superior to pamidronate in the treatment of hypercalcemia of malignancy:a pooled analysis of two randomized,controlled clinical trials[J].J Clin Oncol,2001,19(2):558-567.
  • 6REID IR,BROWN JP,BURCKHARDT P,et al.Intravenous zoledronic acid in postmenopausal women with low bone mineral density[J].N Engl J Med,2002,346(9):653-661.
  • 7ROSEN LS,GORDEN D,KAMINSKI M,et al.Zoledronic acid versus pamidronate in the treatment of skeletal metastases in patients with breast cancer or osteolytic lesions of multiple myeloma:a phase Ⅲ,double-blind,compareative trial[J].Cancer,2001,7(5):377-387.
  • 8ROSEN LS,GORDEN D,KAMINSKI M,et al.Long-term efficacy and safety of zoledronic acid compared with pamidronate disodium in the treatment of skeletal complications in patients with advanced multiple myeloma or breast carcinoma:a randomized,double-blind,multicenter,conparative trial[J].Cancer,2003,98 (8):1735-1744.
  • 9ROSEN LS,GORDEN D,DUGAN W,et al.Zoledronic acid is superior to pamidronate for the treatment of bone metastases in breast carcinoma patients with at least one osteolytic lesion[J].Cancer,2004,100 (1):36-43.
  • 10WEINFURT KP,CASTEL LD,LI Y,et al.Health-related quality of life among patients with breast cancer receiving zoledronic acid or pamidronate disodium for metastatic bone lesions[J].Med Care,2004,42 (2):164-175.

共引文献37

同被引文献67

引证文献7

二级引证文献33

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部